Journal: Annals of Clinican and translational neurology

Filtra

Data

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy

Nusinersen in pediatric and adult patients with type III spinal muscular atrophy

Type I SMA “new natural history”: long-term data in nusinersen-treated patients

Torna in alto